Search
Neracorvir
go.drugbank.com/drugs/DB21630ExperimentalThe usage of the INN stem '-corvir' in the name indicates that Neracorvir is a core protein (Cp) inhibitor. Neracorvir has a monoisotopic molecular weight of 419.12 Da.
Tacaciclib
go.drugbank.com/drugs/DB21644ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor. Tacaciclib has a monoisotopic molecular weight of 528.28 Da.
Fovinaciclib
go.drugbank.com/drugs/DB21721InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor. Fovinaciclib has a monoisotopic molecular weight of 548.3 Da.
Zeprumetostat
go.drugbank.com/drugs/DB21740InvestigationalThe usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor. Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.
Psilocybin
go.drugbank.com/drugs/DB11664InvestigationalPsilocybin has been investigated for the treatment of Anxiety and Stage IV Melanoma. In November, 2019, it was granted Breakthrough Therapy status by the FDA.
mRNA-3351
go.drugbank.com/drugs/DB17718ExperimentalmRNA-3351 is a modified mRNA encoding the UGT1A1 gene. Developed by Moderna, it is currently being investigated as the treatment for Crigler-Najjar syndrome
Tiropramide
go.drugbank.com/drugs/DB13091InvestigationalTiropramide is under investigation in clinical trial NCT01629212 (Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome).
Galamustine
go.drugbank.com/drugs/DB21062ExperimentalThe usage of the INN stem '-mustine' in the name indicates that Galamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Barucainide
go.drugbank.com/drugs/DB19585ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Barucainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Suricainide
go.drugbank.com/drugs/DB19705ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Suricainide is a class I antiarrhythmic, procainamide and lidocaine derivative.